Osteoarthritis pain in cats is ubiquitous, under-diagnosed, and under-treated. Recognition and assessment of pain in cats have improved significantly in recent years. While NSAIDs are the foundation of treating OA pain in other species, none are US-FDA approved for chronic use in cats. A new therapeutic anti-NGF monoclonal antibody is safe and effective for treating OA pain in cats. Overcoming obstacles to medicalizing cats with OA pain requires improved partnering with clients.
Learning Objectives:
Recognize osteoarthritis as an under-diagnosed and under-treated issue in cats
Describe techniques for assessing pain in cats
Evaluate the use of new medications to effectively treat OA pain in cats
Appreciate enhancing and prolonging the human-animal-bond through better management of OA pain